Conselho Nacional de Desenvolvimento Científico e Tecnológico / Depression is a serious, recurrent and incapacitating psychiatric condition with a heavy social burden. The pharmacological approach to this disorder employs therapy with antidepressant drugs, which have side effects and numerous limitations. In view of the promising pharmacological properties of containing-selenium molecules, this study evaluated the effect of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene (DPS) in the mouse forced swim test (FST) and tail suspension test (TST), two models predictive of depressant activity. Since serotonin (5-HT) plays an important role in the pathophysiology of depressive disorders, the involvement of serotonergic system and 5-HT receptors in the action caused by DPS was studied. The antidepressant-like action of combined treatment with subeffective doses of both DPS plus paroxetine, a selective serotonin reuptake inhibitor (SSRI) was investigated. Further, we verified the possible mechanism responsible for antidepressant-like action of DPS. The results showed that DPS (50 and 100 mg/kg, p.o.) significantly reduced the immobility time during the FST and TST, without accompanying changes in ambulation when assessed in the open-field test. The anti-immobility effect of DPS (50 mg/kg, i.g.) in the FST was prevented by pretreatment of mice with pCPA (p-chlorophenylalanine; an inhibitor of 5-HT synthesis, 100 mg/kg, i.p., once a day for 4 consecutive days,), WAY 100635 (N-[2- [4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexane carboxamide; 0.1 mg/kg, s.c., a selective 5-HT1A receptor antagonist), ritanserin (1 mg/kg, i.p., a 5-HT2 receptor antagonist) or ondansetron (1 mg/kg, i.p., a 5-HT3 receptor antagonist). Combined treatment with paroxetine and DPS reduced the immobility time in the FST. DPS at the dose of 50 mg/kg did not produce any change in the cerebral activity of monoamine oxidase subtypes (MAO-A or MAO-B). DPS at the dose of 50 mg/kg inhibited significantly 5-HT uptake in mouse brain synaptosomes. These results suggest that DPS produced an antidepressant-like action in the mouse FST and TST and this action seems most likely to be mediated through an interaction with serotonergic system, particularly by 5-HT reuptake inhibition. / A depressão é uma doença grave, recorrente e uma condição psiquiátrica incapacitante que gera pesados custos sociais. A abordagem farmacológica dessa desordem é feita por meio do emprego de antidepressivos, os quais apresentam efeitos adversos e numerosas limitações. Tendo em vista as promissoras propriedades farmacológicas das moléculas contendo selênio, este estudo avaliou o efeito do 3-(4-fluorofenilselenil)-2,5-difenilselenofeno (DPS) no teste do nado forçado (TNF) e no teste da suspensão da cauda (TSC) em camundongos, dois modelos preditivos de comportamento depressivo. Uma vez que a serotonina (5-HT) desempenha um importante papel na patofisiologia dos transtornos depressivos, o envolvimento do sistema serotoninérgico e dos receptores de 5-HT na ação desenvolvida pelo DPS foi estudado. A ação do tipo antidepressiva do tratamento combinado com doses subefetivas de DPS e paroxetina, um inibidor seletivo da recaptação de serotonina (ISRS) foi investigada. Além disso, o possível mecanismo responsável pela ação do tipo antidepressiva do DPS também foi verificado. Os resultados mostram que o DPS (50 e 100 mg/kg) reduziu significativamente o tempo de imobilidade durante os TSC e TNF, sem causar alterações na atividade locomotora no teste do campo aberto (TCA). O efeito anti-imobilidade do DPS (50 mg/kg, i.g.) no TNF foi prevenido pelo pré-tratamento dos animais com pCPA (p-clorofenilalanina; 100 mg/kg, i.p., administrado uma vez ao dia durante 4 dias consecutivos, um inibidor da síntese de serotonina), WAY 100635 (N-[2-[4-(2-metoxifenil)-1-piperazinil]etil]-N-2- piridinilciclohexano carboxamida; 0,1 mg/kg, s.c., um antagonista seletivo de receptores 5- HT1A), ritanserina (1 mg/kg, i.p., um antagonista seletivo de receptores 5-HT2) ou ondansetrona (1 mg/kg, i.p., um antagonista seletivo de receptores 5-HT3). O tratamento combinado com paroxetina e DPS reduziu o tempo de imobilidade no TNF. O DPS na dose de 50 mg/kg não produziu nenhuma alteração na atividade dos subtipos da monoamino oxidase (MAO-A e MAO-B) cerebral. O DPS na dose de 50 mg/kg inibiu significantemente a captação de 5-HT em sinaptossoma de cérebro de camundongos. Esses resultados sugerem que o DPS produziu uma ação do tipo antidepressiva no TSC e no TNF em camundongos e esta ação parece ser mediada por uma interação com o sistema serotoninérgico, particularmente por uma inibição da recaptação de 5-HT.

Contexte. L’étiologie des comportements antisociaux est complexe et varierait au cours de la vie. Tandis que les études antérieures suggèrent que de nombreux facteurs de risque soient impliqués, plusieurs incertitudes demeurent quant aux gènes spécifiques liés à ces phénotypes et en regard de la nature indépendante ou jointe de leurs contributions avec l’environnement. Objectif. L’objectif de cette thèse est d’étudier la contribution des gènes sérotoninergiques et de la violence parentale aux comportements antisociaux à trois périodes développementales : l’enfance, l’adolescence et le début de l’âge adulte. Méthodologie. Afin d’atteindre cet objectif, les données de 410 participants de l’Étude Longitudinale des Enfants de la Maternelle du Québec (ÉLEMQ), un échantillon populationnel à devis longitudinal et prospectif ayant débuté à l’enfance et s’étant poursuivi à l’âge adulte, ont été analysées. Plusieurs comportements antisociaux ont été mesurés à l’enfance (7 ans à 11 ans), à l’adolescence (15 ans) et au début de l’âge adulte (21 ans) par le biais de plusieurs méthodes et d’informateurs: 1) questionnaires complétés par les enseignants, 2) des entrevues semi-structurées, ou 3) des questionnaires auto-rapportés. Les données relatives à la violence parentale ont été obtenues via les questionnaires complétés de façon rétrospective par les participants à l’âge adulte. Des analyses de régressions négatives binominales ont été réalisées afin de vérifier l’association indépendante et conjointe des variants mesurés dans 11 gènes impliqués dans le système sérotoninergique (HTR1A, HTR2A, HTR2C, HTR5A, HTR6, HTR7, SLC6A4, MAOA, MAOB, TPH-1, TPH-2), deux formes de violence parentale – la violence subie et l’exposition à la violence conjugale – et les comportements antisociaux. Résultats. Les indices cumulatifs de risque génétique dérivés à partir de blocs d’haplotypes des gènes investigués permettaient d’expliquer entre 2% et 8% de la variance des comportements antisociaux, que ces derniers soient mesurés à l’enfance, l’adolescence ou à l’âge adulte. De plus, ces indices multigéniques modifient, dans certains cas, l’association entre la violence subie ou l’exposition à la violence conjugale et les comportements antisociaux. Conclusions. Les résultats de cette thèse soutiennent ceux issus des études antérieures soulignant le rôle des gènes impliqués dans le système sérotoninergique à la manifestation des comportements antisociaux. D’autre part, ces résultats suggèrent l’interaction entre les indices cumulatifs génétiques et la violence parentale à la manifestation de comportements antisociaux de l’enfance à l’âge adulte. Or, ces interactions ne sont pas observées de façon consistante et peuvent prendre diverses formes. L’investigation de l’étiologie génétique et environnementale des comportements antisociaux doit être poursuivie de façon à mieux circonscrire leurs effets synergiques, s’il y a lieu, et afin que ces connaissances puissent, éventuellement, éclairer l’examen des mécanismes impliqués et bonifier les modèles théoriques et conceptuels en découlant. / Background. The etiology of antisocial behaviors is complex, and likely vary across the life course. While the multifactorial nature of these phenotypes is clear, uncertainties remain as to which genes are involved whether or not these genes interact with putative pathogenic environments. Aim. The aim of this thesis is to investigate the unique and joint contributions of serotonergic genes and parental violence in three developmental periods: childhood, adolescence, and early adulthood. Methodology. Data were from 410 male members of the Quebec Longitudinal Study of Kindergarten Children, who were prospectively followed from kindergarten to early adulthood. Antisocial behaviors were assessed in childhood (7-12 years), adolescence (15 years) and early adulthood (21 years) using a multi-method and multi-informant strategy, including teacher ratings, clinical interviews and self-report questionnaires. Negative binominal regressions were used to investigate the main and interaction effects between the cumulative indexes encompassing 11 serotonergic candidate genes (HTR1A, HTR2A, HTR2C, HTR5A, HTR6, HTR7, SLC6A4, MAOA, MAOB, TPH-1, TPH-2), two forms of parental violence – child-directed and child-witnessed parental violence – and antisocial behaviors. Results. Haplotype-based cumulative genetic indexes explained between 2% and 8% of the variance in antisocial behaviors, measured in childhood, adolescence, and early adulthood. Moreover, these multigenic serotonergic risk indexes moderated, in some instances, the association between parental violence and antisocial outcomes. Conclusions. This thesis offers additional support suggesting that the serotonergic candidate genes may be involved in the etiology of antisocial behaviors. It also provides further evidence that these genes may interact with parental violence in antisocial social behaviors exhibited in childhood, adolescence, and early adulthood. However, these interactions did not arise uniformly and took multiple forms. Overall, our findings suggest that the investigation of the genetic and environmental etiology of antisocial behaviors should be pursued to better delineate their synergic effect, if any, and to eventually mobilize this knowledge to inform the search of the underlying mechanisms and to improve our theoretical and conceptual models.

Developmental biology adresses how cells are organised into functional structures and eventually into a whole organism. It is crucial to understand the molecular basis for processes in development, by studying the expression and function of relevant genes and their relationship to each other. A gene function can be studied be creating loss-of-function situations, in which the change in developmental processes is examined in the absense of a functional gene product, or in gain-of-function studies, where a gene product is either intrinsically overproduced or ectopically upregulated. One approach for a loss-of-function situation is the creation of specific mutants in single genes, and the zebrafish (Danio rerio) has proven to be an excellent model organism for this purpose. In this thesis, I report on two forward genetic screens performed to find new mutants affecting brain development, in particular mutants defective in development and function of the midbrain-hindbrain boundary (MHB), an organiser region that patterns the adjacent brain regions of the midbrain and the hindbrain. In the first screen, I could identify 10 specific mutants based on morphology and the analysis of the expression patterns of lim1 and fgf8, genes functioning as early neuronal markers and as a patterning gene, respectively. Three of these mutants lacked an MHB, and by complementation studies, I identified these mutants as being defective in the spg locus. The second screen produced 35 new mutants by screening morphologically and with antibodies against acetylated Tubulin, which marks all axonal scaffolds, and anti-Opsin, which is a marker for photoreceptors in the pineal gland. According to their phenotype, I distributed the mutant lines into 4 phenotypic subgroups, of which the brain morphology group with 18 mutant lines was studied most intensively. In the last part of my thesis, I characterise one of these brain morphology mutants, broken heart. This mutant is defective in axonal outgrowth and locomotion, and shows a striking reduction of serotonergic neurons in the epiphysis and in the raphe nuclei in the hindbrain, structures involved in serotonin and melatonin production. Studies in other model organisms suggested a role of factors from the floor plate and the MHB in induction of the serotonergic neurons in the hindbrain, and using broken heart, I show that Fgf molecules such as Fgf4 and Fgf8 can restore partially the loss of serotonergic neurons in the mutant. I conclude that forward genetic screens are an invaluable tool to generate a pool of mutations in specific genes, which can be used to dissect complex processes in development such as brain development.

Los trastornos emocionales de tipo depresivo y la ansiedad son las formas más prevalentes de enfermedad mental y suponen un serio problema de salud en la sociedad occidental. Recientemente, se ha postulado que el sistema endocannabinoide pueda ser un importante sustrato en el desarrollo de estos trastornos dada su participación en el control de las emociones. Nuestros resultados demuestran que los animales carentes del receptor cannabinoide CB1 manifiestan un fenotipo de tipo depresivo asociado a una deficiencia del factor neurotrófico BDNF en el hipocampo, que podría estar causada por los elevados niveles de glucocorticoides liberados en respuesta al estrés en estos mutantes. Por otra parte, el sistema endocannabinoide participa en los efectos inducidos por la nicotina sobre la ansiedad y en la expresión del síndrome de abstinencia de esta droga. Así, la actividad del receptor CB1 alivia los efectos ansiogénicos de dosis elevadas de nicotina y facilita los efectos ansiolíticos de dosis bajas. Además, la administración del agonista cannabinoide 9-THC atenúa las manifestaciones somáticas y emocionales negativas de la abstinencia de nicotina. En general, considerando los resultados presentados en esta Tesis Doctoral, podemos afirmar que el receptor CB1 participa de forma determinante en la recuperación del balance homeostático del organismo tras la exposición a un estímulo emocional negativo, bien sea una situación estresante aguda o sostenida, o bien una droga que incrementa los niveles de ansiedad o cuya retirada produce abstinencia. / Mood disorders such as depression and anxiety are the most common mental diseases and they suppose a serious health problem in our society. Recently, endocannabinoid system has been postulated to be an important substrate in the development of such disorders taking into account the role exerted by this neuromodulatory system in mood and emotions. Our results demonstrate that CB1 knockout mice exhibit a depressive-like phenotype associated to a deficiency in the neurotrophic factor BDNF in the hippocampus, which could be a consequence of the increased glucocorticoid release in response to stress exposure. On the other hand, the endocannabinoid system participates in nicotine induced effects on anxiety and in the expression of nicotine withdrawal. Thus, CB1 receptor activity attenuates anxiogenic-like effects and facilitates anxiolytic-like responses induced by high or low doses of nicotine, respectively. Moreover, 9-THC administration ameliorates somatic and negative motivational signs of nicotine withdrawal. In summary, the results presented in this Doctoral Thesis indicate that CB1 receptor participates in the recovery of the homeostatic balance after the exposure to negative emotional stimuli, either acute or sustained stress or a drug which induced anxiety-like effects or withdrawal signs after the end of the exposure.

Les cellules souches embryonnaires (cellules ES) sont pluripotentes et ont donc le potentiel de se différencier en cellules des trois feuillets embryonnaires, ainsi qu’en cellules de la lignée germinale. Ces propriétés en font un modèle pour l’étude des mécanismes de prolifération et de différenciation. Le facteur de transcription Lmx1b est impliqué dans la maintenance du phénotype différencié des neurones dopaminergiques mésencéphaliques. Et il a aussi été montré comme un facteur clef dans la différenciation et la maintenance des neurones sérotoninergiques du rhombencéphale générés dans les noyaux du Raphé. Dans ce travail, nous nous sommes intéressés aux capacités de Lmx1b d’influencer la différenciation des cellules ES de souris en neurones sérotoninergiques. La première stratégie adoptée a résulté en une expression ectopique stable de Lmx1b dans les cellules ES et leurs dérivés. Le niveau d’expression de Lmx1b a fortement influencé les capacités de différenciation neuronale des cellules. Puis, l’analyse de marqueurs de différenciation spécifiques a montré une augmentation de l’expression des marqueurs sérotoninergiques, au contraire des marqueurs dopaminergiques ou de neurones moteur. La seconde stratégie a consisté en une surexpression inductible de Lmx1b dans les précurseurs neuraux dérivés de cellules ES pour mimer l’expression physiologique de Lmx1b. Après induction, Lmx1b était bien exprimé dans les cellules durant toutes les étapes de différenciation neuronale. L’activation de l’expression de Lmx1b au stade des colonies neuroépithéliales a aussi résulté en une amélioration de la différenciation sérotoninergique. Les résultats de ce travail soulignent les capacités de Lmx1b à diriger la différenciation des précurseurs neuraux dérivés de cellules ES vers la voie sérotoninergique in vitro. / Pluripotent Embryonic Stem Cells (ESC) have the potential to develop into cells of the three germ layers and of the germ line. Therefore, they are used as a model to study the proliferation and differentiation mechanisms. The LIM homeodomain transcription factor Lmx1b is involved in the maintenance of the differentiated phenotype of midbrain dopaminergic neurons. And it has been also demonstrated to be a key factor in differentiation and maintenance of hindbrain serotonergic neurons generated in the Raphe Nuclei. Here, we explored the capacity of Lmx1b to direct differentiation of mouse ESC (mESC) into serotonergic neurons. In the first approach, stable ectopic expression of Lmx1b was achieved. First, the level of Lmx1b expression was found to strongly influence the capacity of mESC to accomplish neuronal differentiation. Then, analysis of lineage-specific differentiation markers showed an increase in serotonergic markers’ expression by contrast to dopaminergic or motor neurons markers. In the second approach, Lmx1b was over-expressed in mESC-derived neural precursors by an inducible system in order to mimic the physiological onset of Lmx1b expression. After induction, Lmx1b was found to be stably expressed throughout neuronal differentiation. Activation of Lmx1b expression in neuroepithelial colonies resulted in enhancement of serotonergic differentiation, consistently with the stable system results. The results of this work highlight the capacity of Lmx1b to promote the shift of mESC-derived neural precursors toward a serotonergic fate in vitro.